<DOC>
	<DOCNO>NCT00893945</DOCNO>
	<brief_summary>This study involve cancer research purpose assess safety activity type vaccine immune therapy cancer . This vaccine make participant 's immune cell ( call dendritic cell ) obtain blood donation . Dendritic cell ( DCs ) immune cell whose role identify foreign material body ( bacteria , virus , tumor cell ) . When DCs recognize material , use activate cell immune system mount attack foreign material . In Laboratory Molecular Neuro-Oncology , participant 's DCs load sample tumor cell obtain surgical resection . These tumor cell kill laboratory use special protocol , `` fed '' DCs . The DCs `` eat '' material , `` fed '' DCs make vaccine .</brief_summary>
	<brief_title>Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered Patients With Brain Tumors</brief_title>
	<detailed_description>If eligible , decide join research study , get two three shot experimental vaccine , three week apart . You follow period monitor medical record affect experimental treatment .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Screening determine eligibility ( exception HLA haplotyping ) complete within 45 day fo study entry . 1 . Disease Characteristics Histologically confirm brain cancer , review MSKCC . Pathologic examination surgical resection specimen deem suitable quality definitive diagnosis histopathologist . Primary Brain Tumors : Anaplastic astrocytoma Glioblastoma multiforme Anaplastic oligodendroglioma Malignant mixed oligoastrocytoma Secondary ( metastatic ) brain tumor newly diagnose recurrent disease All histological grade disease accept Surgically accessible tumor resection indicate . Tumors may initial resection reresections . Recovery minimum 1x10^7 tumor cell ex vivo require . Patients primary brain tumor must previously treat conventional therapy . 2 . Prior/Concurrent Therapy 1 . Recovered toxicity prior therapy 2 . Biologic Therapy No concurrent immunotherapy prior immunotherapy component current regimen ( autologous DCs , cancer cell , KLH ) 3 . Chemotherapy : No concurrent immunomodulatory chemotherapy therapy Chemotherapy , include temozolomide local chemotherapy Gliadel Wafers , must defer last postvaccine leukapheresis 4 . Endocrine evaluation/therapy : steroid dose great 1mg daily dexamethasone ( equivalent ) 5 . Radiotherapy : No concurrent brain radiation 6 . Surgery : Surgical resection must complete independently study , suitable sample obtain vaccine production 3 . Patient Characteristics 1 . Age : 18 , able give write informed consent . May obtain use legal representation health care proxy 2 . Performance status : Karnofsky 60100 % 3 . Life expectancy : least 46 month 4 . Hematopoietic : WBC great 3,800 Absolute lymphocyte great 500 Absolute neutrophil counter great 1,500/mm^3 Platelets great 100,000/mm^3 Hb great equal 10g/dL 5 . Hepatic : bilirubin le 2mg/dL OR SGOT le 2x ULN 6 . Renal : Creatinine great 2mg/dL 7 . Cardiovascular : No NYHA class III/IV status No active angina , uncontrolled clinically significant cardiac arrythmia , recent ( 6 month ) myocardial infarction 8 . Pulmonary : No symptomatic pulmonary disease pulse oximetry le 93 % room air 9 . Endocrine : No history autoimmune thyroid disease 10 . Radiographic : baseline contrastenhanced MRI CT scan brain post surgical resection 11 . Coagulation : No unexplained INR &gt; 2 Exclusion criterion : No active infection require antibiotic No history HIV , hepatitis B hepatitis C virus infection , history high risk behavior infection ( intravenous drug abuse , men unprotected sex men ) . Laboratory evaluation HIV , hepatitis B , hepatitis C obtain prior study entry No history hypersensitivity vaccine components No history autoimmune vasculitic disease ( include limit systemic lupus erythematosis , Hashimoto 's thyroiditis , rheumatoid arthritis , systemic necrotizing vasculitides ( polyarteritis nodosa group ) , hypersensitivity vasculitis , Wegener 's granulomatosis ) , scleroderma , multiple sclerosis , juvenileonset insulindependent diabetes No medical psychiatric illness social condition , opinion investigator , would interfere adherence study requirement No alcohol drug use dependence , opinion investigator , would interfere adherence study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>